by Team PCM | Nov 16, 2022 | Newsletter
NEW BLOG Navigating Gene Therapies Gene therapies are life-changing for patients. However, the price and complexity of balancing costs and patient outcomes are challenging for benefit payers. Read More. INDUSTRY NEWS Shifting focus for patient engagement in 2022. Ways...
by Team PCM | Nov 16, 2022 | Newsletter
NEW BLOG Validating Your Pharmacy Savings Programs While drug substitutions have clear financial advantages, plan sponsors should vet third-party vendors to ensure they provide savings validation and support participant engagement. Read more. INDUSTRY NEWS More mental...
by Team PCM | Nov 16, 2022 | Newsletter
INTRODUCING A simplified RFP tool Market Check by PCM Dynamically reprice claims Compare multiple contracts See contract vs. market rates Build custom contracts See how it works. INDUSTRY NEWS Health care cost inflation to rise: 8 reasons why. Insulin price cap of $35...
by Team PCM | Nov 16, 2022 | Newsletter
NEW BLOG RFP Questions YouShould be Asking When evaluating a PBM contract at renewal or mid-term market check, brokers and plan sponsors should be asking questions. Questions that lead to a thorough understanding of their current PBM contract so they can negotiate...
by Team PCM | Nov 16, 2022 | Newsletter
NEW BLOG Medical Pharmacy Affects Plan Spend Pharmacy costs get all the press for rising prices; however, brokers and plan sponsors need to consider medical pharmacy if they want a complete picture of plan spend. Read more. INDUSTRY NEWS Biosimilars may be the...
by Team PCM | Nov 15, 2022 | Newsletter
NEW BLOG Lowering Diabetes Medication Costs with Alternative Strategies Identifying and covering therapeutic alternatives to high-cost prescription drugs is key to a diabetic-friendly pharmacy program. Plan partners are making this process easier. Read more. INDUSTRY...